Drug Testing and Analysis-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1104231, encodeId=b81a110423132, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104232, encodeId=a3cf110423227, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561376, encodeId=76a05613e682, content=投稿后多久分配编辑？158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561377, encodeId=4b3c5613e7b9, content=多久分配编辑？ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553886, encodeId=bc45553886ac, content=推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd212073347, createdName=1581f098e1m, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549695, encodeId=abf7549695f3, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:01:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549694, encodeId=9445549694d2, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548857, encodeId=e92154885e99, content=2017-5-12 submission；2017-9-22 revision；2017-11-2 acceptance。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Fri Nov 03 09:20:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503542, encodeId=e161503542f5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：专业的分析杂志，该杂志质量较好，发出来的文章也很利于阅读，并具有还好的研究意义和价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=狼, createdTime=Fri Jun 13 09:55:00 CST 2014, time=2014-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824898, encodeId=442682489874, content=这个杂志还是挺快的，我投了一篇，一个月后大修，修改后一个月接收，然后再一个月proof，然后半个月在线。希望if能再升高点。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Apr 02 12:04:00 CST 2013, time=2013-04-02, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

评审和期刊编辑要求我补实验，就一定要补么，不补行不行？

94 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1104231, encodeId=b81a110423132, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104232, encodeId=a3cf110423227, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561376, encodeId=76a05613e682, content=投稿后多久分配编辑？158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561377, encodeId=4b3c5613e7b9, content=多久分配编辑？ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553886, encodeId=bc45553886ac, content=推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd212073347, createdName=1581f098e1m, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549695, encodeId=abf7549695f3, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:01:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549694, encodeId=9445549694d2, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548857, encodeId=e92154885e99, content=2017-5-12 submission；2017-9-22 revision；2017-11-2 acceptance。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Fri Nov 03 09:20:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503542, encodeId=e161503542f5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：专业的分析杂志，该杂志质量较好，发出来的文章也很利于阅读，并具有还好的研究意义和价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=狼, createdTime=Fri Jun 13 09:55:00 CST 2014, time=2014-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824898, encodeId=442682489874, content=这个杂志还是挺快的，我投了一篇，一个月后大修，修改后一个月接收，然后再一个月proof，然后半个月在线。希望if能再升高点。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Apr 02 12:04:00 CST 2013, time=2013-04-02, status=1, ipAttribution=)]

2021-12-28 学医的彭于晏

对于审稿人好的意见也要回复么？

120 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1104231, encodeId=b81a110423132, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104232, encodeId=a3cf110423227, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561376, encodeId=76a05613e682, content=投稿后多久分配编辑？158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561377, encodeId=4b3c5613e7b9, content=多久分配编辑？ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553886, encodeId=bc45553886ac, content=推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd212073347, createdName=1581f098e1m, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549695, encodeId=abf7549695f3, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:01:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549694, encodeId=9445549694d2, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548857, encodeId=e92154885e99, content=2017-5-12 submission；2017-9-22 revision；2017-11-2 acceptance。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Fri Nov 03 09:20:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503542, encodeId=e161503542f5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：专业的分析杂志，该杂志质量较好，发出来的文章也很利于阅读，并具有还好的研究意义和价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=狼, createdTime=Fri Jun 13 09:55:00 CST 2014, time=2014-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824898, encodeId=442682489874, content=这个杂志还是挺快的，我投了一篇，一个月后大修，修改后一个月接收，然后再一个月proof，然后半个月在线。希望if能再升高点。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Apr 02 12:04:00 CST 2013, time=2013-04-02, status=1, ipAttribution=)]

2018-09-22 大星

投稿后多久分配编辑？158****8231 2018-03-19 00:00:00 发表:
推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月

158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月

303 0

[GetPortalCommentsPageByObjectIdResponse(id=1104231, encodeId=b81a110423132, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104232, encodeId=a3cf110423227, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561376, encodeId=76a05613e682, content=投稿后多久分配编辑？158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561377, encodeId=4b3c5613e7b9, content=多久分配编辑？ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553886, encodeId=bc45553886ac, content=推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd212073347, createdName=1581f098e1m, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549695, encodeId=abf7549695f3, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:01:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549694, encodeId=9445549694d2, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548857, encodeId=e92154885e99, content=2017-5-12 submission；2017-9-22 revision；2017-11-2 acceptance。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Fri Nov 03 09:20:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503542, encodeId=e161503542f5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：专业的分析杂志，该杂志质量较好，发出来的文章也很利于阅读，并具有还好的研究意义和价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=狼, createdTime=Fri Jun 13 09:55:00 CST 2014, time=2014-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824898, encodeId=442682489874, content=这个杂志还是挺快的，我投了一篇，一个月后大修，修改后一个月接收，然后再一个月proof，然后半个月在线。希望if能再升高点。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Apr 02 12:04:00 CST 2013, time=2013-04-02, status=1, ipAttribution=)]

2018-09-22 大星

多久分配编辑？ableall 2017-12-04 10:00:00 发表:
投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。

ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。

260 0

[GetPortalCommentsPageByObjectIdResponse(id=1104231, encodeId=b81a110423132, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104232, encodeId=a3cf110423227, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561376, encodeId=76a05613e682, content=投稿后多久分配编辑？158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561377, encodeId=4b3c5613e7b9, content=多久分配编辑？ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553886, encodeId=bc45553886ac, content=推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd212073347, createdName=1581f098e1m, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549695, encodeId=abf7549695f3, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:01:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549694, encodeId=9445549694d2, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548857, encodeId=e92154885e99, content=2017-5-12 submission；2017-9-22 revision；2017-11-2 acceptance。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Fri Nov 03 09:20:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503542, encodeId=e161503542f5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：专业的分析杂志，该杂志质量较好，发出来的文章也很利于阅读，并具有还好的研究意义和价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=狼, createdTime=Fri Jun 13 09:55:00 CST 2014, time=2014-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824898, encodeId=442682489874, content=这个杂志还是挺快的，我投了一篇，一个月后大修，修改后一个月接收，然后再一个月proof，然后半个月在线。希望if能再升高点。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Apr 02 12:04:00 CST 2013, time=2013-04-02, status=1, ipAttribution=)]

2018-03-19 1581f098e1m

推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月

317 0

[GetPortalCommentsPageByObjectIdResponse(id=1104231, encodeId=b81a110423132, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104232, encodeId=a3cf110423227, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561376, encodeId=76a05613e682, content=投稿后多久分配编辑？158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561377, encodeId=4b3c5613e7b9, content=多久分配编辑？ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553886, encodeId=bc45553886ac, content=推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd212073347, createdName=1581f098e1m, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549695, encodeId=abf7549695f3, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:01:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549694, encodeId=9445549694d2, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548857, encodeId=e92154885e99, content=2017-5-12 submission；2017-9-22 revision；2017-11-2 acceptance。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Fri Nov 03 09:20:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503542, encodeId=e161503542f5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：专业的分析杂志，该杂志质量较好，发出来的文章也很利于阅读，并具有还好的研究意义和价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=狼, createdTime=Fri Jun 13 09:55:00 CST 2014, time=2014-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824898, encodeId=442682489874, content=这个杂志还是挺快的，我投了一篇，一个月后大修，修改后一个月接收，然后再一个月proof，然后半个月在线。希望if能再升高点。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Apr 02 12:04:00 CST 2013, time=2013-04-02, status=1, ipAttribution=)]

2017-12-04 ableall

投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。

341 0

[GetPortalCommentsPageByObjectIdResponse(id=1104231, encodeId=b81a110423132, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104232, encodeId=a3cf110423227, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561376, encodeId=76a05613e682, content=投稿后多久分配编辑？158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561377, encodeId=4b3c5613e7b9, content=多久分配编辑？ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553886, encodeId=bc45553886ac, content=推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd212073347, createdName=1581f098e1m, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549695, encodeId=abf7549695f3, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:01:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549694, encodeId=9445549694d2, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548857, encodeId=e92154885e99, content=2017-5-12 submission；2017-9-22 revision；2017-11-2 acceptance。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Fri Nov 03 09:20:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503542, encodeId=e161503542f5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：专业的分析杂志，该杂志质量较好，发出来的文章也很利于阅读，并具有还好的研究意义和价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=狼, createdTime=Fri Jun 13 09:55:00 CST 2014, time=2014-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824898, encodeId=442682489874, content=这个杂志还是挺快的，我投了一篇，一个月后大修，修改后一个月接收，然后再一个月proof，然后半个月在线。希望if能再升高点。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Apr 02 12:04:00 CST 2013, time=2013-04-02, status=1, ipAttribution=)]

2017-12-04 ableall

投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。

333 0

[GetPortalCommentsPageByObjectIdResponse(id=1104231, encodeId=b81a110423132, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104232, encodeId=a3cf110423227, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561376, encodeId=76a05613e682, content=投稿后多久分配编辑？158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561377, encodeId=4b3c5613e7b9, content=多久分配编辑？ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553886, encodeId=bc45553886ac, content=推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd212073347, createdName=1581f098e1m, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549695, encodeId=abf7549695f3, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:01:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549694, encodeId=9445549694d2, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548857, encodeId=e92154885e99, content=2017-5-12 submission；2017-9-22 revision；2017-11-2 acceptance。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Fri Nov 03 09:20:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503542, encodeId=e161503542f5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：专业的分析杂志，该杂志质量较好，发出来的文章也很利于阅读，并具有还好的研究意义和价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=狼, createdTime=Fri Jun 13 09:55:00 CST 2014, time=2014-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824898, encodeId=442682489874, content=这个杂志还是挺快的，我投了一篇，一个月后大修，修改后一个月接收，然后再一个月proof，然后半个月在线。希望if能再升高点。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Apr 02 12:04:00 CST 2013, time=2013-04-02, status=1, ipAttribution=)]

2017-11-03 ableall

2017-5-12 submission；2017-9-22 revision；2017-11-2 acceptance。

395 0

[GetPortalCommentsPageByObjectIdResponse(id=1104231, encodeId=b81a110423132, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104232, encodeId=a3cf110423227, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561376, encodeId=76a05613e682, content=投稿后多久分配编辑？158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561377, encodeId=4b3c5613e7b9, content=多久分配编辑？ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553886, encodeId=bc45553886ac, content=推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd212073347, createdName=1581f098e1m, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549695, encodeId=abf7549695f3, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:01:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549694, encodeId=9445549694d2, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548857, encodeId=e92154885e99, content=2017-5-12 submission；2017-9-22 revision；2017-11-2 acceptance。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Fri Nov 03 09:20:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503542, encodeId=e161503542f5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：专业的分析杂志，该杂志质量较好，发出来的文章也很利于阅读，并具有还好的研究意义和价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=狼, createdTime=Fri Jun 13 09:55:00 CST 2014, time=2014-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824898, encodeId=442682489874, content=这个杂志还是挺快的，我投了一篇，一个月后大修，修改后一个月接收，然后再一个月proof，然后半个月在线。希望if能再升高点。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Apr 02 12:04:00 CST 2013, time=2013-04-02, status=1, ipAttribution=)]

2014-06-13 狼

审稿速度:1.0 | 投稿命中率:25.0
经验分享：专业的分析杂志，该杂志质量较好，发出来的文章也很利于阅读，并具有还好的研究意义和价值。

425 0

[GetPortalCommentsPageByObjectIdResponse(id=1104231, encodeId=b81a110423132, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104232, encodeId=a3cf110423227, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561376, encodeId=76a05613e682, content=投稿后多久分配编辑？158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=158****8231 2018-03-19 00:00:00 发表: 推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561377, encodeId=4b3c5613e7b9, content=多久分配编辑？ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=ableall 2017-12-04 10:00:00 发表: 投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a3d1646861, createdName=大星, createdTime=Sat Sep 22 00:00:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553886, encodeId=bc45553886ac, content=推荐这个杂志.主编人很好.杂志不用版面费和审稿费.但是从接收到见刊过程漫长.我用了10个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd212073347, createdName=1581f098e1m, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549695, encodeId=abf7549695f3, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:01:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549694, encodeId=9445549694d2, content=投的稿件为药代类文章，5-12 submission；9-22 revision；11-3acceptance；11-21 proof correction。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Mon Dec 04 10:00:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548857, encodeId=e92154885e99, content=2017-5-12 submission；2017-9-22 revision；2017-11-2 acceptance。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUE0TtnTJiam1Bd77Xxg3k1cdaqiaQzYBzXtdvPpO8NGb4oYic9QyYpMXhIeK2ibpG1h1F9TWOC20kFw/132, createdBy=4f452097822, createdName=ableall, createdTime=Fri Nov 03 09:20:00 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503542, encodeId=e161503542f5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：专业的分析杂志，该杂志质量较好，发出来的文章也很利于阅读，并具有还好的研究意义和价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=狼, createdTime=Fri Jun 13 09:55:00 CST 2014, time=2014-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824898, encodeId=442682489874, content=这个杂志还是挺快的，我投了一篇，一个月后大修，修改后一个月接收，然后再一个月proof，然后半个月在线。希望if能再升高点。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Apr 02 12:04:00 CST 2013, time=2013-04-02, status=1, ipAttribution=)]

2013-04-02 ms7405767186922736

这个杂志还是挺快的，我投了一篇，一个月后大修，修改后一个月接收，然后再一个月proof，然后半个月在线。希望if能再升高点。

0 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务